![]() |
|
|
JS Fine, TA Gasiewicz and AE Silverstone
Department of Biophysics, University of Rochester School of Medicine, New York 14642.
Perinatal exposure of experimental animals to the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads to thymic atrophy and a suppression of cell-mediated immunity that is more severe and persistent than that caused by adult exposure, suggesting that events involved in the maturation of the immune system are particularly sensitive to TCDD. We report here that perinatal TCDD exposure produces an alteration in the lymphocyte stem cell population in the fetus and neonate, as evidenced by a significant reduction in the lymphocyte stem cell-specific enzyme terminal deoxynucleotidyl transferase (TdT). After maternal treatment with a single dose of TCDD (10 micrograms/kg of body weight) on gestational day (gd) 14, TdT biosynthesis and TdT-specific mRNA were reduced more than 50% in fetal liver lymphoid cells on gd 18. An even more extensive reduction was seen in neonatal bone marrow through postnatal day 18. In contrast, thymic TdT synthesis appeared to be relatively unaffected on a per cell basis by perinatal TCDD exposure, although the actual number of TdT-synthesizing thymocytes was diminished due to extensive thymic atrophy. These effects occurred at concentrations of 1-31 fg of TCDD/mg of thymus. Flow cytometric analysis of thymocyte surface marker expression revealed a slight decrease in the percentage of Lyt-2+L3T4+ thymocytes on gd 18 and postnatal day 4. This alteration was no longer apparent by postnatal day 11, when marrow TdT biosynthesis was most suppressed. These results suggest that TCDD-induced thymic atrophy during the perinatal period may be due, in part, to an effect on the prothymocyte.
This article has been cited by other articles:
![]() |
D. A. Weinstein, R. M. Gogal Jr, A. Mustafa, M. R. Prater, and S. D. Holladay Mid-gestation Exposure of C57BL/6 Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Postnatal Morphologic Changes in the Spleen and Liver Toxicol Pathol, July 1, 2008; 36(5): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Hogaboam, A. J. Moore, and B. P. Lawrence The Aryl Hydrocarbon Receptor Affects Distinct Tissue Compartments during Ontogeny of the Immune System Toxicol. Sci., March 1, 2008; 102(1): 160 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Camacho, M. Nagarkatti, and P. S. Nagarkatti Evidence for Induction of Apoptosis in T Cells from Murine Fetal Thymus following Perinatal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Toxicol. Sci., March 1, 2004; 78(1): 96 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Laiosa, Z.-W. Lai, T. S. Thurmond, N. C. Fiore, C. DeRossi, B. C. Holdener, T. A. Gasiewicz, and A. E. Silverstone 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Alterations in Lymphocyte Development and Thymic Atrophy in Hemopoietic Chimeras Generated from Mice Deficient in ARNT2 Toxicol. Sci., September 1, 2002; 69(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J Smialowicz The rat as a model in developmental immunotoxicology Human and Experimental Toxicology, September 1, 2002; 21(9-10): 513 - 519. [Abstract] [PDF] |
||||
![]() |
S D Holladay and B L Blaylock The mouse as a model for developmental immunotoxicology Human and Experimental Toxicology, September 1, 2002; 21(9-10): 525 - 531. [Abstract] [PDF] |
||||
![]() |
Regulations and Advisories Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201. [PDF] |
||||
![]() |
S. M. Heidel, K. Holston, J. T.M. Buters, F. J. Gonzalez, C. R. Jefcoate, and C. J. Czupyrynski Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene Mol. Pharmacol., December 1, 1999; 56(6): 1317 - 1323. [Abstract] [Full Text] |
||||
![]() |
J. E. Staples, F. G. Murante, N. C. Fiore, T. A. Gasiewicz, and A. E. Silverstone Thymic Alterations Induced by 2,3,7,8-Tetrachlorodibenzo- p-Dioxin Are Strictly Dependent on Aryl Hydrocarbon Receptor Activation in Hemopoietic Cells J. Immunol., April 15, 1998; 160(8): 3844 - 3854. [Abstract] [Full Text] [PDF] |
||||